FDA describes legal limits of drug compounding

被引：0

|

作者：

不详

机构：

来源：

AMERICAN JOURNAL OF VETERINARY RESEARCH | 2020年 / 81卷 / 02期

关键词：

D O I：

暂无

中图分类号：

S85 [动物医学（兽医学）];

学科分类号：

0906 ;

摘要：

引用

收藏

页码：99 / 99

页数：1

相关论文

共 50 条

[21] FDA revives compounding advisory committee
Traynor, Kate
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (08) : 598 - 599
[22] FDA states policy on pharmacy compounding
Young, D
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (13) : 1222 - +
[23] FDA Addresses Compounding at Outsourcing Facilities
JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (06) : 19N - 19N
[24] FDA Compounding Quality Center of Excellence
不详
JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (03) : 21N - 21N
[25] FDA draft guidance on compounding and repackaging
Reactions Weekly, 2015, 1540 (1) : 2 - 2
[26] Berlex continues legal challenge to FDA over MS drug
Glaser, V
NATURE BIOTECHNOLOGY, 1996, 14 (07) : 811 - 812
[27] FDA Remains Hampered in Inspecting Compounding Facilities
Mitka, Mike
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (10): : 1015 - 1015
[28] FDA continues to uncover concerning compounding practices
Reactions Weekly, 2013, 1449 (1) : 3 - 3
[29] Compounding pharmacies' lawsuit against FDA will continue
Chiarello, Kaylynn
Pharmaceutical Technology, 2005, 29 (07)
[30] FDA sees trend of unsafe compounding labs
Cima, Greg
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2019, 254 (07): : 767 - 768

← 1 2 3 4 5 →